10 most important contemporary challenges in the management of SLE.

Archive ouverte

Felte, Renaud | Sagez, Flora | Gavand, Pierre-Edouard | Martin, Thierry | Korganow, Anne-Sophie | Sordet, Christelle | Javier, Rose-Marie | Soulas-Sprauel, Pauline | Rivière, Marianne | Scher, Florence | Poindron, Vincent | Guffroy, Aurélien | Arnaud, Laurent

Edité par CCSD ; BMJ -

From a 1-year survival of less than 50% before the discovery of glucocorticoids to over 90% at 10 years in most dedicated centres, the spectrum of SLE has profoundly evolved. Despite this improvement, several major challenges currently remain. The aim of this review is to analyse what are, according to us, the 10 most important contemporary challenges in the management of SLE. Among those are the need to treat to target to favour disease remission (or low disease activity), limit the use of glucocorticoids, derive more comprehensive tools for the evaluation of disease activity, develop more effective drugs (yielding successful trials), dissect the heterogeneity of the disease both at the molecular and genetic levels, identify relevant biomarkers for individualised treatment, manage fertility and pregnancy, tackle comorbidities such as cardiovascular risk, the prevention of infections and osteoporosis, improve the network of care (from the patients' perspective), and favour a holistic approach (integrating fatigue, adherence to treatment, physical activity). Altogether, these 10 contemporary challenges in SLE may be considered as a roadmap for those involved in the daily care of patients with SLE, as well as for researchers who may wish to contribute to an improved management of this rare and complex disease.

Suggestions

Du même auteur

Worldwide trends in all-cause mortality of auto-immune systemic diseases between 2001 and 2014

Archive ouverte | Scherlinger, Marc | CCSD

Incidence and predictors of COVID-19 and flares in patients with rare autoimmune diseases: a systematic survey and serological study at a national reference center in France

Archive ouverte | Felten, Renaud | CCSD

International audience. Background The risk of severe COVID-19 and its determinants remain largely unknown in patients with autoimmune and inflammatory rheumatic diseases. The objective of this study was to assess t...

T1 mapping cardiac magnetic resonance imaging frequently detects subclinical diffuse myocardial fibrosis in systemic sclerosis patients.

Archive ouverte | Poindron, Vincent | CCSD

cardiac involvement is the second most frequent systemic sclerosis (SSc) related cause of death. It remains mostly asymptomatic in the early stage and is underdiagnosed with routine screening. Cardiac magnetic resonance imaging (C...

Chargement des enrichissements...